ADCYAP1 and migraine disorder: In addition, there is emerging evidence that neuropeptidergic pathways involved in migraine, such as those involving CGRP and pituitary cyclase activating polypeptide 38 (PACAP38), may interact with the kynurenine pathway in migraine, and therefore pose a potential therapeutic substrate [89,92].